The Motley Fool

2 earnings results you might have missed on Friday

With earnings season now seemingly in overdrive, it is understandable that a number of results may have slipped under the radar today.

Two which I think are worth taking a look at are listed below. Here’s what they delivered:

The Apiam Animal Health Ltd (ASX: AHX) share price climbed almost 8% to 77.5 cents after the veterinary products provider posted full-year underlying EBITDA of $8.3 million on revenue of $98 million. This hit the upper end of the guidance the company provided in May and came courtesy of a strong second-half.

Pleasingly, management has a positive outlook for FY 2018 and believes that it has moved beyond the industry issues that impacted the company’s performance in the first-quarter of FY 2017. Whilst things do look to be improving, I would sooner invest in Greencross Limited (ASX: GXL) or National Veterinary Care Ltd (ASX: NVL) at this point.

The Regis Healthcare Ltd (ASX: REG) share price tumbled almost 2% to $3.69 after the aged care operator announced its full-year results. Investors clearly weren’t overly impressed with the company’s 8% increase in net profit after tax to $61.1 million.

Profit growth was far slower than that of rival Estia Health Ltd (ASX: EHE) which reported an impressive 47% increase in net profit after tax yesterday. But given the tailwinds of Australia’s ageing population, both companies could be in position to deliver a solid FY 2018 in my opinion.

5 stocks under $5

We hear it over and over from investors, "I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I'd be sitting on a gold mine!" And it's true.

And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

*Extreme Opportunities returns as of June 5th 2020

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Greencross Limited. We Fools may not all hold the same opinions, but we all believe that considering a makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Related Articles...

Latest posts by James Mickleboro (see all)